Video PlayerClose
Emma Walmsley, chief executive officer of GlaxoSmithKline, addresses the parallel session "Opening-up, Regulation and Business Environment" of the second Hongqiao International Economic Forum in Shanghai, east China, Nov. 5, 2019. (Xinhua/Fang Zhe)